Clinical Trials Directory

Trials / Terminated

TerminatedNCT02370355

Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer

Assessment of Novel Biomarkers in Patients With Metastatic Castration Resistant Prostate Cancer

Status
Terminated
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
Male
Age
19 Years
Healthy volunteers
Not accepted

Summary

This research trial studies molecular characterization of circulating tumor cells (CTCs) and circulating tumor (ct) deoxyribonucleic acid (DNA) in blood and plasma samples from patients with prostate cancer that has spread to other places in the body and/or has not responded to previous treatment with hormones. Studying samples of blood and plasma collected from patients with prostate cancer before, during, and/or after treatment in the laboratory may help doctors learn more about changes that occur in DNA and identify the development of drug resistance.

Detailed description

PRIMARY OBJECTIVES: I. Perform molecular analysis of plasma samples from 25 patients with metastatic prostate cancer collected before and during treatment of the disease with abiraterone acetate (Zytiga) or enzalutamide (Xtandi). II. Perform molecular characterization of circulating tumor cells (CTCs) and plasma collected from 75 patients with progressing advanced metastatic prostate cancer. OUTLINE: Patients are assigned to 1 of 2 groups based on the timing of specimen collection. GROUP I: Previously collected plasma samples are analyzed for ctDNA via polymerase chain reaction (PCR) and next generation sequencing (NSG). GROUP II: Patients undergo collection of blood samples before and following systemic therapy for analysis of CTC enumeration, ribonucleic acid (RNA) expression, and ctDNA via PCR and NSG.

Conditions

Interventions

TypeNameDescription
OTHERCytology Specimen Collection ProcedureUndergo collection of blood samples
OTHERLaboratory Biomarker AnalysisCorrelative studies

Timeline

Start date
2014-12-23
Primary completion
2016-06-08
Completion
2016-06-08
First posted
2015-02-24
Last updated
2017-04-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02370355. Inclusion in this directory is not an endorsement.